Diagnosis of avascular necrosis of the femoral head in patients treated for lymphoma
โ Scribed by Dr Marcia A. Ratcliffe; Fiona J. Gilbert; Audrey A. Dawson; Bruce Bennett
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 557 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Avascular necrosis of bone (AVNB) is a wellโknown but rare complication of chemotherapy for lymphoma with a reported incidence ranging from 1 to 10 per cent. Early diagnosis is essential for optimal therapeutic management. Using MRI, the most sensitive means of detecting the earlier stages of AVNB, 100 patients treated with standard chemotherapy for lymphoma were assessed. Fifteen were found to have changes of AVNB, 10 with early changes but five with advanced segmental collapse of the femoral head. None with AVNB had more than the standard course of corticosteroids.
Almost a quarter of the study group complained of joint pain during and/or after their treatment, a third of whom were found to have AVNB; a strong indicator to screen all those with pain. However, 40 per cent of those with AVNB were asymptomatic. The clinical significance of theโsilent hipโ is yet to be elucidated.
๐ SIMILAR VOLUMES
## Abstract ## Purpose To detect alteration of the fatty component by measuring the in vivo lipid and water content of normalโlooking femoral heads of patients with and without risk for avascular necrosis (AVN) by using proton MR spectroscopy (MRS). ## Materials and Methods Marrow composition wa
## Abstract ## Purpose To evaluate the apparent diffusion coefficient (ADC) of femoral head avascular necrosis (AVN) in severe acute respiratory syndrome (SARS). ## Materials and Methods Seventyโnine SARS patients with hip pain underwent both conventional and diffusionโweighted MRI (bโvalue = 0โ
Four adult patients with malignant lymphoma were treated with combination chemotherapy including an alkylating agent, vincristine, procarbazine (in all but one case), and intermittent high-dose prednisone. Twenty to 42 months after initiation of therapy, osteonecrosis of the femoral head developed.